Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
PhD student Åsmund Husabø Eikenes from Harald Stenmark's group at the Department of Molecular Cell Biology at Oslo University Hospital and The Centre for Cancer Biomedicine (CCB) at the University of Oslo has contributed with a new article in the Norwegian newspaper Aftenposten about the recurring questions: What does it take to solve the cancer riddle? And why do I get cancer?
In her blog on www.forskning.no, postdoc Sigrid Thoresen, also from Stenmark's group and CCB, writes about whether cancer is a question of good or bad luck?
Everyone is welcome to the next Oslo University Hospital research seminar, which is entitled "PhD students and supervisors: the fast tracks to perfect synergy?" Themes that will be discussed:
What are the roles of PhD students and supervisors in a PhD study?
Where to find help for new supervisors and students to maximize research outcome?
Time: Monday, February 2nd, 2015, at 14:30-16:00.
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Leiv Arne Rosseland, head of research at the Division of Division of Emergencies and Critical Care, has recently contributed to the Oslo University Hospital research blog (in Norwegian). He discusses factors that are important for relieving pain during childbirth.
Nano Today (impact factor 18.4) publishes on their homepage a list of the most cited articles in the journal published since 2010. This list now shows the review article “Endocytosis and intracellular transport of nanoparticles. Present knowledge and need for future studies” by Tore Geir Iversen, Tore Skotland and Kirsten Sandvig at the Institute for Cancer Research to be number 3 on this list.
Theis Tønnesen, head of research at the Division of Cardiovascular and Pulmonary Diseases, has recently contributed to the Oslo University Hospital research blog. His article focuses on the importance of good research dissemination.
The Norwegian Radium Hospital Research Foundation will also for 2015 distribute resources to photodynamic therapy and photochemical internalization (PDT/PCI) related research. In 2014 various research projects within this field were founded with a total of NOK 1,25 million. Employees at the Oslo University Hospital are welcome to apply.
The closing date for applications is February 13th, 2015.
PhD students and supervisors: the fast tracks to perfect synergy?
Jan 29, 2015
A novel cell penetrating peptide as vector for therapeutic vaccine
Jan 21, 2015
Inst. for Cancer Research
?-Adrenergic Receptor Signaling in Prostate Cancer
Front Oncol, 4, 375
Measurements of carotid intima media thickness in non-invasive high-frequency ultrasound images: the effect of dynamic range setting
Cardiovasc Ultrasound, 13 (1), 5 (in press)
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
An ER clamp for endosome fission
EMBO J, 34 (2), 136-7